Clinical Trial Update: Second-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing second-line irinotecan and capecitabine versus irinotecan for biliary tract cancer after gemcitabine and cisplatin failure has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Biliary Tract Neoplasms

Drugs mentioned

• Capecitabine (capecitabine)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Zhejiang University | Conditions: Biliary Tract Neoplasms | Phase 2 | Status: COMPLETED